The content of matrix metalloproteinase-1,-9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity

被引:0
|
作者
Kachkovska, V. V. [1 ]
Prystupa, L. N. [2 ]
机构
[1] Sumy State Univ, Ctr Resp Med, Dept Internal Med, UA-40007 Sumy, Ukraine
[2] Sumy State Univ, Ctr Resp Med, Internal Med, Sumy, Ukraine
来源
PATHOLOGIA | 2023年 / 20卷 / 03期
关键词
asthma; obesity; matrix metalloproteinase-1; matrix metalloproteinase-9; tissue inhibitor of metalloproteinase-1; course; control;
D O I
10.14739/2310-1237.2023.3.291212
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Airway remodeling is a significant factor in the progression of respiratory failure in bronchial asthma (BA). Obesity can contribute to inflammation, and consequently - airway remodeling, by increased production of matrix proteinase (MMP). However, the mechanisms of remodeling in different phenotypes of BA, especially in comorbid patients, remain poorly understood.The aim of the research was to examine the levels of remodeling markers MMP-1, MMP-9 and tissue inhibitor of matrix proteinases (TIMP-1) in obese asthmatic patients, taking into account their age at the onset of BA, the severity of symptoms and the level of control. Material and methods. 195 patients with BA associated with obesity were examined. The control group consisted of 95 practically healthy people. Patients were divided into two groups: Group I included 100 patients with early onset, and Group II included 95 patients with late onset of BA. The study was approved by the Bioethics Commission of the Medical Institute of Sumy State University. Statistical analysis of the obtained results was carried out using the SPSS-17 program.Results. The content of MMP-1,-9 and TIMP-1 was higher in patients with early (129.40 +/- 7.86; 177.30 +/- 9.19; 142.40 +/- 12.22 ng/ml, respectively) and late (196.60 +/- 9.62; 289.80 +/- 16.23; 187.50 +/- 11.34 ng/ml, respectively) BA with obesity compared to practically healthy individuals (p < 0.005). Patients with late-onset BA associated with obesity likely had higher indicators than those with early BA. In patients with early BA, the levels of MMP-1,-9, and TIMP-1 were not significantly different depending on the severity of the disease (p > 0.05). However, in patients with severe late BA, the levels of these markers were higher compared to those with mild BA (p < 0.05). Levels of MMP-1 and MMP-9 in patients with early-onset and late-onset BA with obesity were higher in the absence of disease control compared to those in complete and partial control, but in late-onset exceeded those in early-onset.Conclusions. Considering the obtained results, it can be assumed that the level of MMP-1, MMP-9 and TIMP-1 in obese patients with BA can serve as biomarkers of airway remodeling, namely, the severity and the level of BA control.
引用
收藏
页码:238 / 242
页数:5
相关论文
共 50 条
  • [1] Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis
    Wang, Ying-De
    Yan, Pei-Yun
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (37) : 6050 - 6053
  • [3] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [4] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [5] Sputum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio in acute asthma
    Tanaka, H
    Miyazaki, N
    Oashi, K
    Tanaka, S
    Ohmichi, M
    Abe, S
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) : 900 - 905
  • [6] Matrix metalloproteinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
    Derosa, Giuseppe
    D'Angelo, Angela
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    Pricolo, Fabio
    Salvadeo, Sibilla
    Montagna, Lorenza
    Gravina, Alessia
    Ferrari, Ilaria
    Galli, Simona
    Paniga, Sonia
    Tinelli, Carmine
    Cicero, Arrigo F. G.
    [J]. ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2006, 13 (03): : 227 - 231
  • [7] Association of matrix metalloproteinase-1, matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1, and interleukin-6 with epicardial and myocardial perfusion
    Tanindi, Asli
    Sahinarslan, Asife
    Elbeg, Sehri
    Cemri, Mustafa
    [J]. CORONARY ARTERY DISEASE, 2011, 22 (04) : 253 - 258
  • [8] Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 levels in Exudative Pleural Effusions
    Cho, Jae Hwa
    Nam, Jeong Hyeon
    Lee, Kyum Ho
    Yoon, Byeong Kab
    Ryu, Jeong Sun
    Kwak, Sung Min
    Lee, Hong Lyeol
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2005, 59 (05) : 517 - 521
  • [9] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    [J]. BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [10] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618